戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ased from the C-terminus of mZP2 and mZP3 by carboxypeptidase B.
2 idues in HPRG, and by treatment of HPRG with carboxypeptidase B.
3 bomodulin complex activated all the mutants, carboxypeptidase B activity of the activated mutants aga
4 llowed detection limits of 1-2 pM enzyme for carboxypeptidase B and activated thrombin-activatable fi
5  carboxypeptidase-U, carboxypeptidase-R, pro-carboxypeptidase-B, and thrombin-activatable fibrinolysi
6 mZP2 and mZP3, Arg residues were released by carboxypeptidase B, consistent with processing at the co
7 HTRF) assay has been developed for measuring carboxypeptidase B (CPB) activity in a miniaturized high
8                         Thrombin-activatable carboxypeptidase B (CPB), also called thrombin-activatab
9                                       Plasma carboxypeptidase B (CPB), which is activated by the thro
10  surface and are sensitive to proteolysis by carboxypeptidase B (CpB).
11  to 2.05-A resolution and demonstrate robust carboxypeptidase B-like activity for the enzyme.
12 n be activated by thrombin to an enzyme with carboxypeptidase B-like activity.
13                       After release of FPB a carboxypeptidase-B-like enzyme removes the carboxyl-term
14                                       Plasma carboxypeptidase B (PCB) is an exopeptidase that exerts
15                        The ability of plasma carboxypeptidase B (pCPB) to remove these residues sugge
16  the crystal structure of porcine pancreatic carboxypeptidase B (pp-CpB) in complex with a variety of
17 Da glycosylated carboxypeptidase, plasma pro-carboxypeptidase B (pro-plasma CPB), has recently been i
18 ment of the Cpefat/Cpefat brain extract with carboxypeptidase B restores the level of Leu-enkephalin
19 s B, C and F bound to the surrogate protease carboxypeptidase B revealed the binding modes of these l
20 ral product inhibitors in a modified porcine carboxypeptidase B revealed their binding mode and provi
21                                              Carboxypeptidase B-sensitive plasminogen binding sites p
22 pped forms, the sample is treated first with carboxypeptidase B to reduce the charge microheterogenei
23         The cap is subsequently removed with carboxypeptidase B to yield mature biologically active I
24 ys]Pg activation kinetics with wild-type SK, carboxypeptidase B-treated SK, and a COOH-terminal Lys41
25                                              Carboxypeptidase B treatment decreased cell-dependent pl
26                                              Carboxypeptidase B treatment eliminated the increment in
27 ean trypsin inhibitor and was susceptible to carboxypeptidase B treatment, implicating proteolysis an
28  the enzymatic activity and concentration of Carboxypeptidase B was developed.
29 ombining targeted specific proteolysis using carboxypeptidase B with a proteomics approach using two-

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。